0000899243-19-005202.txt : 20190228
0000899243-19-005202.hdr.sgml : 20190228
20190228160938
ACCESSION NUMBER: 0000899243-19-005202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190226
FILED AS OF DATE: 20190228
DATE AS OF CHANGE: 20190228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARNER CAM L
CENTRAL INDEX KEY: 0001024007
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19643264
MAIL ADDRESS:
STREET 1: PO BOX 675866
CITY: RANCHO SANTE FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-26
0
0001375151
ZOGENIX, INC.
ZGNX
0001024007
GARNER CAM L
C/O ZOGENIX, INC.
5858 HORTON STREET, #455
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2019-02-26
4
M
0
4756
12.00
A
4756
D
Common Stock
2019-02-26
4
S
0
4756
50.00
D
0
D
Common Stock
2019-02-27
4
M
0
869
12.00
A
869
D
Common Stock
2019-02-27
4
S
0
869
50.00
D
0
D
Common Stock
40843
I
By Garner Investments, LLC
Stock Option (Right to Buy)
12.00
2019-02-26
4
M
0
4756
0.00
D
2023-06-18
Common Stock
4756
869
D
Stock Option (Right to Buy)
12.00
2019-02-27
4
M
0
869
0.00
D
2023-06-18
Common Stock
869
0
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The Reporting Person is the managing member of Garner Investments, LLC.
The Option was granted on June 18, 2013 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Cam L. Garner
2019-02-28